Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Niklas Schone
Introduction
Niklas Schone is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on the acylation of rapamycin. His expertise and dedication to research have led to the development of a unique patent that showcases his skills as an inventor.
Latest Patents
Niklas Schone holds a patent for the "Regioselective acylation of rapamycin at the C-42 position." This invention pertains to the selective acylation of rapamycin at the 42-position using an acylating agent. The acylating agent is defined by a specific formula, wherein R and R' can be the same or different, representing various chemical structures such as an acetal, carbonate, or silyl ether. This innovative approach has the potential to enhance the efficacy of rapamycin in therapeutic applications.
Career Highlights
Niklas Schone is currently employed at Sandoz GmbH, a leading company in the pharmaceutical industry. His work at Sandoz has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in drug development. His commitment to innovation is evident in his patent and ongoing projects.
Collaborations
Niklas has worked closely with his coworker Wolfgang Felzmann, sharing insights and expertise to advance their research initiatives. Their collaboration has fostered a productive environment that encourages the exchange of ideas and innovative solutions.
Conclusion
Niklas Schone's contributions to the field of pharmaceuticals through his patent on the regioselective acylation of rapamycin highlight his role as a significant inventor. His work at Sandoz GmbH and collaboration with colleagues further emphasize his commitment to innovation in drug development.